logo
Wrong email address or username
Wrong email address or username
Incorrect verification code
back to top
Search tags: cdss
Load new posts () and activity
Like Reblog Comment
text 2021-09-24 08:36
Clinical Decision Support Systems (CDSS) Market Will Grow At A CAGR Of 6.7% In Future

Global Clinical Decision Support Systems Market is expected to reach USD 791.25 million by 2024. Clinical Decision Support System is also termed, as CDSS is an application that recognizes data to support healthcare providers make clinical decisions. It is a version of the decision support system exclusively used to support business management. To prepare a diagnosis and evaluation of the diagnosis as a means of refining the concluding result. The Clinical Decision Support System (CDSS) Market is estimated to grow at a significant CAGR of 6.7% over the future period as the scope and its applications are rising enormously across the globe.

 

The increasing government initiatives, growing aging population, acceptance of HCIT solutions in healthcare, and growing number of people suffering from chronic diseases are documented as major factors of clinical decision support systems industry that are estimated to enhance the growth in the years to come. However, saturated end-user market and lack of skilled personnel are the factors that may restrain overall market growth in the forecast period. Clinical Decision Support System industry is segmented based on types, product types, delivery mode, components, user inactivity, application, and region.

 

Diagnostics CDSS and Standalone CDSS are the types that could be explored in Clinical Decision Support System in the years to come. There are various product types of Clinical Decision Support System that could be explored in forecast period are Integrated CDSS with CPOE & E.H.R., Standalone CDSS, Integrated E.H.R. with CDSS, Integrated CPOE with CDSS, and others. Clinical Decision Support System integrated with CPOE segment accounts for the largest market share of overall market and is estimated to lead the market in the coming years. Moreover, it is estimated to grow at highest CAGR in the upcoming years. This may be because of, acceptance of computerized prescription patterns in developed regions.

 

The market is categorized based on delivery mode like On-Premises Delivery, Web Delivery, Cloud Delivery, and others. On-premises mode is exclusively preferred due to information safety and privacy issues. It is estimated to lead the overall market in the years to come. Also, cloud-based delivery segment is estimated to grow at highest CAGR in the upcoming years.

 

The software sector is at topmost position due to the need for intervallic software upgradation. However, Services and Hardware are other components that could be explored in Clinical Decision Support System in the future period. The services may include Post-sale and Maintenance Services, Consulting Services, Training and Education Services, and Ongoing IT support and Implementation Services.

 

Passive CDSS and Active CDSS are the user interactivity that could be explored in Clinical Decision Support System in the upcoming years. Also, the market is categorized based on applications like Drug Dosing Support, Drug-Drug Interactions, Clinical Guidelines, Drug Allergy Alerts, Clinical Reminders, and others. The drug allergy alerts sector is estimated to lead the overall market in the foremost period. However, drug dosing support and drug-drug interactions follow suit.

 

Request a Free Sample Copy of Clinical Decision Support Systems (CDSS) Market Report @ https://www.millioninsights.com/industry-reports/clinical-decision-support-systems-cdss-market/request-sample

 

Globally, North America accounts for the largest market share of Clinical Decision Support System and is estimated to remain dominant in the years to come. The reason behind the growth of market in this region could be, rising importance on quality of healthcare services, technological enhancement, and presence of reimbursement policies. The United States may be a major consumer of Clinical Decision Support System in this region in forecast period. Instead, Europe and the Asia Pacific are also estimated to have a positive influence on the future growth.

 

However, Asia Pacific is estimated to grow at fastest pace with the highest CAGR of 7.8% in the years to come. The aspects that may be ascribed to the growth comprise, increasing investments in the healthcare sector in countries like Singapore, Australia, India, and China. In addition, developing countries like India and China are the major consumers of Clinical Decision Support System in this region.

 

The key players of Clinical Decision Support System Market are Siemens Healthcare, EPIC Systems Corporation Inc., Phillips Healthcare, International Business Machines (IBM), Cerner Corporation, Elsevier B.V., McKesson Corporation, Zynx Health, Medical Information Technology, Inc., Wolters Kluwer Health, and Allscripts Healthcare Solutions. These players are concentrating on inorganic growth to sustain themselves amongst fierce competition. As such, mergers, acquisitions, and joint ventures are the need of the hour.

 

Market Segment:

 

Clinical Decision Support Systems Product Outlook (Revenue, USD Million, 2013 - 2024)
• Standalone CDSS
• Integrated CPOE with CDSS
• Integrated E.H.R. with CDSS
• Integrated CDSS with CPOE & E.H.R.

 

Clinical Decision Support Systems Application Outlook (Revenue, USD Million, 2013 - 2024)
• Drug-drug interactions
• Drug allergy alerts
• Clinical reminders
• Clinical guidelines
• Drug dosing support
• Others

 

Clinical Decision Support Systems Delivery Mode Outlook (Revenue, USD Million, 2013 - 2024)
• Web Delivery
• Cloud Delivery
• On Premises Delivery

 

The report “Clinical Decision Support Systems (CDSS) Market” is available now at https://www.millioninsights.com/industry-reports/clinical-decision-support-systems-cdss-market 

 

Clinical Decision Support Systems Component Outlook (Revenue, USD Million, 2013 - 2024)
• Hardware
• Software
• Services

 

Clinical Decision Support Systems Regional Outlook (Revenue, USD Million, 2013 - 2024)
• North America
• U.S.
• Canada
• Europe
• Germany
• U.K.
• Asia Pacific
• Japan
• China
• Latin America
• Brazil
• Middle East and Africa (MEA)
• South Africa

Like Reblog Comment
text 2021-06-30 06:44
Clinical Decision Support Systems (CDSS) Market Size, Growth, Segments, Revenue, Manufacturers & Forecast Report Till 2024

Global Clinical Decision Support Systems Market is expected to reach USD 791.25 million by 2024. Clinical Decision Support System is also termed, as CDSS is an application that recognizes data to support healthcare providers make clinical decisions. It is a version of the decision support system exclusively used to support business management. To prepare a diagnosis and evaluation of the diagnosis as a means of refining the concluding result. The Clinical Decision Support System (CDSS) Market is estimated to grow at a significant CAGR of 6.7% over the future period as the scope and its applications are rising enormously across the globe.

 

Access Sample Report of this report @ https://bit.ly/3hmGlYD

 

 

The increasing government initiatives, growing aging population, acceptance of HCIT solutions in healthcare, and growing number of people suffering from chronic diseases are documented as major factors of clinical decision support systems industry that are estimated to enhance the growth in the years to come. However, saturated end-user market and lack of skilled personnel are the factors that may restrain overall market growth in the forecast period. Clinical Decision Support System industry is segmented based on types, product types, delivery mode, components, user inactivity, application, and region.

 

Diagnostics CDSS and Standalone CDSS are the types that could be explored in Clinical Decision Support System in the years to come. There are various product types of Clinical Decision Support System that could be explored in forecast period are Integrated CDSS with CPOE & E.H.R., Standalone CDSS, Integrated E.H.R. with CDSS, Integrated CPOE with CDSS, and others. Clinical Decision Support System integrated with CPOE segment accounts for the largest market share of overall market and is estimated to lead the market in the coming years. Moreover, it is estimated to grow at highest CAGR in the upcoming years. This may be because of, acceptance of computerized prescription patterns in developed regions.

 

The market is categorized based on delivery mode like On-Premises Delivery, Web Delivery, Cloud Delivery, and others. On-premises mode is exclusively preferred due to information safety and privacy issues. It is estimated to lead the overall market in the years to come. Also, cloud-based delivery segment is estimated to grow at highest CAGR in the upcoming years.

 

The software sector is at topmost position due to the need for intervallic software upgradation. However, Services and Hardware are other components that could be explored in Clinical Decision Support System in the future period. The services may include Post-sale and Maintenance Services, Consulting Services, Training and Education Services, and Ongoing IT support and Implementation Services.

Passive CDSS and Active CDSS are the user interactivity that could be explored in Clinical Decision Support System in the upcoming years. Also, the market is categorized based on applications like Drug Dosing Support, Drug-Drug Interactions, Clinical Guidelines, Drug Allergy Alerts, Clinical Reminders, and others. The drug allergy alerts sector is estimated to lead the overall market in the foremost period. However, drug dosing support and drug-drug interactions follow suit.

 

Globally, North America accounts for the largest market share of Clinical Decision Support System and is estimated to remain dominant in the years to come. The reason behind the growth of market in this region could be, rising importance on quality of healthcare services, technological enhancement, and presence of reimbursement policies. The United States may be a major consumer of Clinical Decision Support System in this region in forecast period. Instead, Europe and the Asia Pacific are also estimated to have a positive influence on the future growth.

 

Browse Complete Report Summary with TOC here https://bit.ly/2TlmUHJ

 

However, Asia Pacific is estimated to grow at fastest pace with the highest CAGR of 7.8% in the years to come. The aspects that may be ascribed to the growth comprise, increasing investments in the healthcare sector in countries like Singapore, Australia, India, and China. In addition, developing countries like India and China are the major consumers of Clinical Decision Support System in this region.

 

The key players of Clinical Decision Support System Market are Siemens Healthcare, EPIC Systems Corporation Inc., Phillips Healthcare, International Business Machines (IBM), Cerner Corporation, Elsevier B.V., McKesson Corporation, Zynx Health, Medical Information Technology, Inc., Wolters Kluwer Health, and Allscripts Healthcare Solutions. These players are concentrating on inorganic growth to sustain themselves amongst fierce competition. As such, mergers, acquisitions, and joint ventures are the need of the hour.

 

Get in touch

At Million Insights, we work with the aim to reach the highest levels of customer satisfaction. Our representatives strive to understand diverse client requirements and cater to the same with the most innovative and functional solutions.

 

Contact Person:

Ryan Manuel

Research Support Specialist, USA

Email:ryan@millioninsights.com

Source: bit.ly/3hmGlYD
Like Reblog Comment
text 2019-05-16 08:29
Clinical Decision Support System Market Overview, Share and Forecast Report 2022

The CDSS market is driven by five major factors, including growing demand for advanced healthcare information systems, growing investments by HIT players, growing need for remote patient monitoring services, and increasing support from government organizations.

 

Request for report sample at: https://www.psmarketresearch.com/market-analysis/clinical-decision-support-system-market/report-sample

 

The massive unexplored CDSS across the globe has created abundant opportunities for the major players to exploit the potential of the CDSS market. Although, there has been significant development in the developed economies of European Union (EU) and the U.S., the clinical decision support system market is still at its nascent form, especially in the developing countries of Asia, Latin America, and Africa. A high growth in numbers of end user including hospitals, and pharmacy has been witnessed in the developing countries of these regions, which provides immense growth opportunities for the CDSS market.

 

The Asia-Pacific market for CDSS is expected to grow at a CAGR of 23.2% between 2016-2022. The clinical decision support system market in Asia-Pacific is growing, due to growing geriatric population and upsurge in the occurrence rate of different chronic diseases. In addition, the improving healthcare infrastructure, and favorable government support, such as investments and grants has fueled the demand of HIT systems including CDSS in the region. China is expected to grow at a CAGR of 27% during the forecast period and reach $114.3 million by 2022, in the Asia-Pacific CDSS market.

 

Browse full report at: https://www.psmarketresearch.com/market-analysis/clinical-decision-support-system-market

 

Some of the key companies operating in the CDSS market include Cerner Corporation, RELX Group PLC, Epic Systems Corporation, General Electric Company, McKesson Corporation, Zynx Health Incorporated, International Business Machine Corporation, Siemens AG, Allscripts Healthcare Solutions Inc., Meditech and Wolters Kluwer.

Source: www.psmarketresearch.com
More posts
Your Dashboard view:
Need help?